I hope the best for that Australian doctor diagnosed with GBM.
On a purely pragmatic note, Dr. Bosch stated many years ago, and I’m paraphrasing, the problem with human selected peptide vaccines to attempt treating mutating heterogeneous cancers is that we (human beings) aren’t smart enough at this time to pick all the right targets, and even when we luck out, those targets then mutate.
That’s why Doctor Ashkan continually points out the genius of Dendritic Cells emanating from millions of evolutionary years fine tuning their interactions with the rest of the immune system, so that target selection is relevant and adaptable.
Market Data 
Markets 
